https://www.news-medical.net/news/20240123/New-study-reveals…tment.aspx ASMicrobiology
In a recent study published in the American Society for Microbiology, researchers developed a novel rabbit infection model to investigate meropenem’s resistance development potential and antibacterial efficacy.
Study: Molecular pharmacodynamics of meropenem for nosocomial pneumonia caused by Pseudomonas aeruginosa. Image Credit: Sam Rana/Shutterstock.com.
Background
Meropenem is an antibacterial drug representing the current gold standard in hospital-acquired pneumonia (HAP) care.
Leave a reply